151 related articles for article (PubMed ID: 16685215)
1. Investigation of aldosterone-synthase inhibition in rats.
Ménard J; Gonzalez MF; Guyene TT; Bissery A
J Hypertens; 2006 Jun; 24(6):1147-55. PubMed ID: 16685215
[TBL] [Abstract][Full Text] [Related]
2. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
[TBL] [Abstract][Full Text] [Related]
3. Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?
Ménard J; Pascoe L
J Hypertens; 2006 Jun; 24(6):993-7. PubMed ID: 16685193
[TBL] [Abstract][Full Text] [Related]
4. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium intake on aldosterone and corticosterone production, the serum sodium concentration and body weight in infant rats during weaning period.
Erdösová R; Kraus M
Physiol Bohemoslov; 1976; 25(1):1-6. PubMed ID: 131329
[TBL] [Abstract][Full Text] [Related]
6. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
7. StAR expression and the long-term aldosterone response to high-potassium diet in Wistar-Kyoto and spontaneously hypertensive rats.
Peters B; Teubner P; Clausmeyer S; Puschner T; Maser-Gluth C; Wrede HJ; Kränzlin B; Peters J
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E16-23. PubMed ID: 16882930
[TBL] [Abstract][Full Text] [Related]
8. Neuronal nitric oxide synthase-deficient mice have impaired renin release but normal blood pressure.
Sällström J; Carlström M; Jensen BL; Skøtt O; Brown RD; Persson AE
Am J Hypertens; 2008 Jan; 21(1):111-6. PubMed ID: 18091753
[TBL] [Abstract][Full Text] [Related]
9. The effect of diet on simvastatin and losartan enhancement of endothelial function.
Bayorh MA; Layas MF; Mann G; Feuerstein GZ; Eatman D
Clin Exp Hypertens; 2007 Jul; 29(5):311-25. PubMed ID: 17653966
[TBL] [Abstract][Full Text] [Related]
10. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
[TBL] [Abstract][Full Text] [Related]
11. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
12. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
[TBL] [Abstract][Full Text] [Related]
13. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats.
Pere AK; Krogerus L; Mervaala EM; Karppanen H; Ahonen J; Lindgren L
Surgery; 2000 Jul; 128(1):67-75. PubMed ID: 10876188
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis.
Jonassen TE; Petersen JS; Sørensen AM; Andreasen F; Christensen S
J Pharmacol Exp Ther; 1998 Dec; 287(3):931-6. PubMed ID: 9864275
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
[TBL] [Abstract][Full Text] [Related]
17. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
18. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
Lantis AC; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
Am J Vet Res; 2011 Dec; 72(12):1646-51. PubMed ID: 22126693
[TBL] [Abstract][Full Text] [Related]
19. Diuretics and bone loss in rats with aldosteronism.
Law PH; Sun Y; Bhattacharya SK; Chhokar VS; Weber KT
J Am Coll Cardiol; 2005 Jul; 46(1):142-6. PubMed ID: 15992648
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
Rigel DF; Fu F; Beil M; Hu CW; Liang G; Jeng AY
J Pharmacol Exp Ther; 2010 Jul; 334(1):232-43. PubMed ID: 20354176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
